Stacy Markel - 27 Feb 2026 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role: CHIEF PEOPLE OFFICER
Signature: /s/ Stephen Dang, Attorney-in-Fact
Issuer symbol: NUVB
Transactions as of: 27 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 03 Mar 2026, 19:59:11 UTC
Previous filing: 18 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Markel Stacy	CHIEF PEOPLE OFFICER	C/O NUVATION BIO INC., 1500 BROADWAY, SUITE 1401, NEW YORK	/s/ Stephen Dang, Attorney-in-Fact	03 Mar 2026	0001734780

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NUVB	Class A Common Stock						32,591	27 Feb 2026	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NUVB	Stock Option (Right to Buy)	Award	$0	+748,130		$0.000000	748,130	27 Feb 2026	Class A Common Stock	748,130	$5.91	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 3,000 shares acquired on November 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan.
F2	Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.